FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 14:27:08 2024-06-05 EDT | ||
| 12.51 EUR | -0.40% |
|
| Current month | +4.42% | ||
| 1 month | -5.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-05 | 12.51 | -0.40% |
| 24-06-04 | 12.56 | +2.28% |
| 24-06-03 | 12.28 | +2.50% |
| 24-05-31 | 11.98 | +0.93% |
| 24-05-30 | 11.87 | +6.27% |
Real-time BOERSE MUENCHEN
Last update June 05, 2024 at 02:27 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GH81U0 |
| ISIN | DE000GH81U03 |
| Date issued | 2021-06-28 |
| Strike | 204.9 $ |
| Maturity | Unlimited |
| Parity | 7.65 : 1 |
| Emission price | 9.97 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.32 € |
|---|---|
| Lowest since issue | 5.551 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.89%
- Stock Market
- Certificates
- Certificat
